Cargando…

Small-Dose Sunitinib Modulates p53, Bcl-2, STAT3, and ERK1/2 Pathways and Protects against Adenine-Induced Nephrotoxicity

The therapeutic use of numerous pharmacological agents may be limited due to their nephrotoxicity and associated kidney injury. The aim of our study is to test the hypothesis that the blockade of tyrosine kinase-linked receptors signaling protects against chemically induced nephrotoxicity. To test o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Saleh, Mohamed A., Awad, Ahmed M., Ibrahim, Tarek M., Abu-Elsaad, Nashwa M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7698013/ https://www.ncbi.nlm.nih.gov/pubmed/33212804 http://dx.doi.org/10.3390/ph13110397

Ejemplares similares

Erlotinib can halt adenine induced nephrotoxicity in mice through modulating ERK1/2, STAT3, p53 and apoptotic pathways
por: Awad, Ahmed M., et al.
Publicado: (2020)

Immunohistochemical distribution of Bcl-2 and p53 apoptotic markers in acetamiprid-induced nephrotoxicity
por: Nur, Gokhan, et al.
Publicado: (2022)

Zinc oxide nanoparticles and spironolactone-enhanced Nrf2/HO-1 pathway and inhibited Wnt/β-catenin pathway in adenine-induced nephrotoxicity in rats
por: Awadalla, Amira, et al.
Publicado: (2022)

TLR4‐IN‐C34 protects against acute kidney injury via modulating TLR4/MyD88/NF-κb axis, MAPK, and apoptosis
por: Abdelsalam, Hadeer M., et al.
Publicado: (2022)

ROR2 increases the chemoresistance of melanoma by regulating p53 and Bcl2-family proteins via ERK hyperactivation
por: Castro, María Victoria, et al.
Publicado: (2022)

Correction to: ROR2 increases the chemoresistance of melanoma by regulating p53 and Bcl2-family proteins via ERK hyperactivation
por: Castro, María Victoria, et al.
Publicado: (2022)

Structures of p53/BCL-2 complex suggest a mechanism for p53 to antagonize BCL-2 activity
por: Wei, Hudie, et al.
Publicado: (2023)

Thymoquinone decreases F-actin polymerization and the proliferation of human multiple myeloma cells by suppressing STAT3 phosphorylation and Bcl2/Bcl-(XL )expression
por: Badr, Gamal, et al.
Publicado: (2011)

Control of Mitochondrial Membrane Permeabilization by Adenine Nucleotide Translocator Interacting with HIV-1 Viral Protein R and Bcl-2
por: Jacotot, Etienne, et al.
Publicado: (2001)

Possible Protective Effect of Diacerein on Doxorubicin-Induced Nephrotoxicity in Rats
por: Refaie, Marwa M. M., et al.
Publicado: (2016)

Expression of bcl-2 and p53 in bovine cutaneous fibropapillomas
por: Bocaneti, Florentina, et al.
Publicado: (2015)

Scorpion Venom Causes Upregulation of p53 and Downregulation of Bcl-x(L) and BID Protein Expression by Modulating Signaling Proteins Erk(1/2) and STAT3, and DNA Damage in Breast and Colorectal Cancer Cell Lines
por: Al-Asmari, Abdulrahman Khazim, et al.
Publicado: (2017)

Aberrant immunoexpression of p53 tumour-suppressor and Bcl-2 family proteins (Bcl-2 and Bax) in ameloblastomas and odontogenic keratocysts
por: Escobar, Enrico, et al.
Publicado: (2023)

Mutual Relations between Substituent Effect, Hydrogen Bonding, and Aromaticity in Adenine-Uracil and Adenine-Adenine Base Pairs †
por: Wieczorkiewicz, Paweł A., et al.
Publicado: (2020)

The tissue dependent interactions between p53 and Bcl-2 in vivo
por: Li, Xin, et al.
Publicado: (2015)

Sunitinib: the antiangiogenic effects and beyond
por: Hao, Zhonglin, et al.
Publicado: (2016)

Cell proliferation, cell loss and expression of bcl-2 and p53 in human pulmonary neoplasms.
por: Kennedy, M. M., et al.
Publicado: (1997)

Patterns of Immunohistochemical Expression of P53, BCL2, PTEN, and HER2/neu Tumor Markers in Specific Breast Cancer Lesions
por: Bealy, Mohamed Ahmed, et al.
Publicado: (2022)

Hepatocellular Carcinoma cells: activity of Amygdalin and Sorafenib in Targeting AMPK /mTOR and BCL-2 for anti-angiogenesis and apoptosis cell death
por: El-Sewedy, Tarek, et al.
Publicado: (2023)

Trypanosoma brucei adenine-phosphoribosyltransferases mediate adenine salvage and aminopurinol susceptibility but not adenine toxicity()
por: Lüscher, Alexandra, et al.
Publicado: (2013)

Chloroquine Intervenes Nephrotoxicity of Nilotinib through Deubiquitinase USP13‐Mediated Stabilization of Bcl‐XL
por: Yan, Hao, et al.
Publicado: (2023)

Evidence of reciprocity of bcl-2 and p53 expression in human colorectal adenomas and carcinomas.
por: Watson, A. J., et al.
Publicado: (1996)

Deregulation of apoptosis mediators' p53 and bcl2 in lung tissue of COPD patients
por: Siganaki, Marianna, et al.
Publicado: (2010)

Effects of enalapril and paricalcitol treatment on diabetic nephropathy and renal expressions of TNF-α, p53, caspase-3 and Bcl-2 in STZ-induced diabetic rats
por: Ahmed, Osama M., et al.
Publicado: (2019)

Immunohistochemical detection of p53 and Bcl-2 in colorectal carcinoma: no evidence for prognostic significance.
por: Tollenaar, R. A., et al.
Publicado: (1998)

Prognostic relevance of sunitinib toxicities and comparison of continuous vs. intermittent sunitinib dosing schedule in metastatic renal cell cancer patients
por: Ordu, Çetin, et al.
Publicado: (2016)

Blockage of Glyoxalase I Inhibits Colorectal Tumorigenesis and Tumor Growth via Upregulation of STAT1, p53, and Bax and Downregulation of c-Myc and Bcl-2
por: Chen, Yuan, et al.
Publicado: (2017)

The complexity of sunitinib dosing in renal cell cancer patients
por: Desar, Ingrid M.E., et al.
Publicado: (2012)

Expression of caspase-3, p53 and Bcl-2 in generalized aggressive periodontitis
por: Bulut, Şule, et al.
Publicado: (2006)

Bcl-2 protein expression: association with p53 and prognosis in colorectal cancer.
por: Kaklamanis, L., et al.
Publicado: (1998)

Expression of Bcl-2 and p53 at the fetal-maternal interface of rhesus monkey
por: Wei, Peng, et al.
Publicado: (2005)

Overexpression of Bcl-2 induces STAT-3 activation via an increase in mitochondrial superoxide
por: Kang, Jia, et al.
Publicado: (2015)

Dose-related nephrotoxicity of carboplatin in children
por: English, M W, et al.
Publicado: (1999)

Apatinib promotes autophagy and apoptosis through VEGFR2/STAT3/BCL-2 signaling in osteosarcoma
por: Liu, Kuisheng, et al.
Publicado: (2017)

Hyperbaric oxygen treatment and nephrotoxicity induced by gentamicin in rats
por: Berkovitch, Matitiahu, et al.
Publicado: (2017)

Adrenomedullin blockade suppresses sunitinib-resistant renal cell carcinoma growth by targeting the ERK/MAPK pathway
por: Gao, Yongqian, et al.
Publicado: (2016)

Design, Synthesis, Chemical and Biochemical Insights Into Novel Hybrid Spirooxindole-Based p53-MDM2 Inhibitors With Potential Bcl2 Signaling Attenuation
por: Aziz, Yasmine M. Abdel, et al.
Publicado: (2021)

p53 and bcl-2 expression in high-grade B-cell lymphomas: correlation with survival time.
por: Piris, M. A., et al.
Publicado: (1994)

TP53 mutations confer resistance to hypomethylating agents and BCL-2 inhibition in myeloid neoplasms
por: Schimmer, Roman R., et al.
Publicado: (2022)

2-Methoxyestradiol TPGS Micelles Attenuate Cyclosporine A-Induced Nephrotoxicity in Rats through Inhibition of TGF-β1 and p-ERK1/2 Axis
por: Al-Rabia, Mohammed W., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_viah7hk33bqbi114ribh6u6e7q